gr 65630 has been researched along with Muscle Contraction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujii, A; Inoue, A; Kohno, Y; Nakata, Y; Negishi, Y; Nishio, H | 1 |
| Fujishima, Y; Ozaki, A; Sukamoto, T | 1 |
2 other study(ies) available for gr 65630 and Muscle Contraction
| Article | Year |
|---|---|
5-HT3 receptor blocking properties of the antiparkinsonian agent, talipexole.
Topics: Animals; Azepines; Bromocriptine; Cerebral Cortex; Dopamine Antagonists; Emetics; Female; Guinea Pigs; Heart Atria; Ileum; Imidazoles; In Vitro Techniques; Indoles; Male; Membranes; Muscle Contraction; Muscle, Smooth; Rats; Rats, Wistar; Receptors, Serotonin; Serotonin Antagonists; Tachycardia | 1996 |
Selective 5-hydroxytryptamine3 (5-HT3) receptor blocking activity of KB-R6933, a novel benzimidazole derivative.
Topics: Animals; Benzimidazoles; Binding, Competitive; Bradycardia; Guinea Pigs; Ileum; Imidazoles; Indoles; Male; Muscle Contraction; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Tritium | 1999 |